Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Recalls Monitoring: Internal Efficiency Grows, But Website Lags

This article was originally published in The Silver Sheet

Executive Summary

DEVICE RECALLS FALL 10% IN 2003, returning to 2001 level, with 527 actions reported. FDA is using its new Recall Enterprise System to electronically track each recall, but has yet to launch the long-promised public arm of the system. Meanwhile, agency staff say a manufacturer’s overall state of control may be called into question by a recall. "When you call me about a recall, you’re telling me that the quality control system in your firm works or it doesn’t work," says a Detroit compliance officer. To avoid a warning letter after a recall, companies should investigate why the problem occurred and take action to prevent a recurrence, agency staff advise

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036085

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel